India's Cipla launching coronavirus treatment drug Ciplenza in August
The company said it will commercially launch Ciplenza in the first week of August and each tablet has been priced less than a dollar.
Ciplenza has been jointly developed by Cipla and CSIR-Indian Institute of Chemical Technology.
India on Friday reported the number of coronavirus cases in the country have reached 1,287,945 including 30,601 deaths. Globally India is the third worst-hit country due to the coronavirus pandemic. ■